The study gives for the first time information about the point prevalence of both immunological and nonimmunological adverse reactions to food and underlines the relevance of this issue in public health. The data also show that an individualized stepwise approach including provocation tests is mandatory to confirm the diagnosis.
Oncogenic Kit mutations are found in somatic gastrointestinal (GI) stromal tumors (GISTs) and mastocytosis. A mouse model for the study of constitutive activation of Kit in oncogenesis has been produced by a knock-in strategy introducing a Kit exon 11-activating mutation into the mouse genome based on a mutation found in a case of human familial GIST syndrome. Heterozygous mutant Kit V558⌬ ͞؉ mice develop symptoms of disease and eventually die from pathology in the GI tract. Patchy hyperplasia of Kit-positive cells is evident within the myenteric plexus of the entire GI tract. Neoplastic lesions indistinguishable from human GISTs were observed in the cecum of the mutant mice with high penetrance. In addition, mast cell numbers in the dorsal skin were increased. Therefore Kit V558⌬ ͞؉ mice reproduce human familial GISTs, and they may be used as a model for the study of the role and mechanisms of Kit in neoplasia. Importantly, these results demonstrate that constitutive Kit signaling is critical and sufficient for induction of GIST and hyperplasia of interstitial cells of Cajal. Kit encodes a growth factor receptor with ligand-dependent tyrosine kinase activity (1-3). Kit ligand (KitL) is the only known ligand of the Kit receptor (4). KitL binding to the receptor mediates receptor dimerization, activation of kinase activity, and autophosphorylation. Subsequently, Kit activates several signaling cascades, leading to cell proliferation, cell survival, and other cellular responses. Kit and KitL are encoded at the White spotting (W) and Steel (Sl) loci in the mouse, respectively (4-6). Mutations at the murine W and Sl loci generate deficiencies in several major cell systems during embryogenesis and in the postnatal animal: in hematopoiesis, melanogenesis, gametogenesis, and intestinal pacemaker cells. In hematopoiesis Kit receptor signaling is critical in the stem cell hierarchy, erythropoiesis, mast cell development and function, megakaryopoiesis, and lymphopoiesis (7-10). Interstitial cells of Cajal (ICC) function as pacemaker cells in the gastrointestinal (GI) tract and they mediate inputs from the enteric nervous system to smooth muscle cells. ICC express the Kit receptor tyrosine kinase and inhibition of Kit function interferes with the autonomous movement of the GI tract (11-13).GI stromal tumor (GIST) is the most common mesenchymal neoplasm of the human intestinal tract. GISTs are a heterogeneous group of tumors, which historically had been classified either as leiomyoma, leiomyosarcoma, or GI autonomic nerve tumors (14). GISTs express Kit and they are thought to derive from a Kit ϩ or Kit low ICC progenitor or ICC through somatic mutation, based on immunophenotypic and ultrastructural similarities (15).Originally, we had identified Kit as the oncogene of an acute transforming feline retrovirus, the HZ4-FeSV (1). However, a role for Kit in human neoplasia has been emerging only more recently. First, human and murine mast cell lines were found to carry Kit-activating mutations in the activation loop of the kinas...
The perception of food-related symptoms is common among children and adolescents from the general population. Self-reports could be confirmed in around one out of 10 individuals, still resulting in 4.2% of proven clinical symptoms. However, most reactions were mild and mainly because of pollen-associated FA, while NAFH reactions were less common. Severe IgE-mediated FA was observed in individuals with pre-existing atopic disease, who should be fully investigated for clinically relevant FA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.